Israel Web3 Basketball Community (@nbatopshot_il) 's Twitter Profile
Israel Web3 Basketball Community

@nbatopshot_il

NBA Fans, Gamers, Collectors and Investors, welcome to the Israeli Web3 Basketball Community 🇮🇱🏀 | @NBATopShot | @SorareNBA | @knightsofdegen | and more!

ID: 1358997660779307008

calendar_today09-02-2021 04:35:01

2,2K Tweet

624 Takipçi

599 Takip Edilen

Brad Turell (@bradturell) 's Twitter Profile Photo

Great way to end the season & set himself up for 24-25! Last 5 games 13.6 ppg 4 Rebs 50%FG 44% 3FG! Enjoy! Ryan Turell ERUPTS for a Career-High 34 PTS (5 3PT) vs. Raptors! youtu.be/uM94GO-gDjA?si… via YouTube

NBA University (@nba_university) 's Twitter Profile Photo

Deni Avdija since Feb 1: 18.7 PPG 60.4 TS% 37.8 3P%—4.1 3PA/g 9.4 RPG 3.6 APG Wiz -7.1 Net with him on the court & -14.0 w/o. At 6’9, he gets downhill & finishes strong. Heady secondary playmaker. Versatile defender. Shot falling. 23 years old—will be a decade-long NBA starter.

Deni Avdija since Feb 1:

18.7 PPG
60.4 TS%
37.8 3P%—4.1 3PA/g
9.4 RPG
3.6 APG

Wiz -7.1 Net with him on the court & -14.0 w/o. At 6’9, he gets downhill & finishes strong. Heady secondary playmaker. Versatile defender. Shot falling. 23 years old—will be a decade-long NBA starter.
Packrip Ewing (@packripewing) 's Twitter Profile Photo

To honor this Chad’s big buy, I’m giving away 55,000 in $Bets. To enter: 🔵 reply to this tweet saying $bets is based. 🔵 retweet this post Let’s have some fun. @AllStreetBetsV1

Brett Usher (@ushernba) 's Twitter Profile Photo

Deni Avdija since Feb. 1 (26 GP): 18.7 PPG 9.1 RPG 3.5 APG 1.5 3P/G 60.8% TS The 23-year-old is a two-way versatile building block on a team-friendly contract (front-loaded $13.8M/yr avg. through 2027-28) and he’s only getting better #ForTheDistrict

Deni Avdija since Feb. 1 (26 GP):

18.7 PPG
9.1 RPG
3.5 APG
1.5 3P/G
60.8% TS

The 23-year-old is a two-way versatile building block on a team-friendly contract (front-loaded $13.8M/yr avg. through 2027-28) and he’s only getting better 

#ForTheDistrict
Stand With Israel Coin (@standwithcoin) 's Twitter Profile Photo

The Stand With Israel Coin $ISR is live! CA: 6GUgAR8ESY6iLp39VX2dWm6JTF2ppf7ybNPATUCXBRDA Website: standwithisraelcoin.com TG: t.me/StandWithIsrsel

MONKΞ D SL0PPY (@jme0x42069) 's Twitter Profile Photo

On behalf of the @AllStreetBetsV1 community I’ll be giving away a random @BAYC303 after their public mint phase closes. 🎁 1. Must be following @AllStreetBetsV1 , @BAYC303 and myself JMΞ . 2. Wallet must hold $BETS at the time winner is announced 3. Like & retweet

On behalf of the @AllStreetBetsV1 community I’ll be giving away a random @BAYC303 after their public mint phase closes. 🎁 

1. Must be following @AllStreetBetsV1 , @BAYC303 and myself <a href="/jme0x42069/">JMΞ</a> . 

2. Wallet must hold $BETS at the time winner is announced 

3. Like &amp; retweet
GB (@gbinisrael) 's Twitter Profile Photo

There’s hope for Jason! Amazingly the same week Jason Collins came out sharing he has GBM, heroically stating: “If that's all the time I have left, I'd rather spend it trying a course of treatment that might one day be a new standard of care for everyone” Is the same week

Portland Trail Blazers (@trailblazers) 's Twitter Profile Photo

his time is NOW ‼️ Voting is LIVE for #NBAAllStar2026! Let's show the league what Rip City stands for — hustle, heart, and grit. Cast your vote for your Rip City All-Stars NOW! 🔗: nba.com/blazers/allsta…

his time is NOW ‼️

Voting is LIVE for #NBAAllStar2026! Let's show the league what Rip City stands for — hustle, heart, and grit. Cast your vote for your Rip City All-Stars NOW!

🔗: nba.com/blazers/allsta…
Alpha Tau Insight (@alphatauinsight) 's Twitter Profile Photo

Just in: Cathie Wood of ARK is buying nearly $2M worth of Alpha Tau Medical stock $DRTS. The stock will be entering her $IZRL ETF on January 16th.

Alpha Tau Insight (@alphatauinsight) 's Twitter Profile Photo

🚨WATCH: $DRTS CEO after the stock surges on the Japanese approval news: We’re not looking to raise capital, we’re finishing FDA Phase 3 trial this quarter, Pancreas trial in H1 this year, GBM trial also this year, starting new trials and are forming strategic partnerships.